Delivery Order SPE2DB24D1205-SPE2DB25FDAMX
Award Date 9/15/25
Potential Completion Date 9/16/25
Potential Value $35K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $6,768.87 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trelegy Ellipta 100-62.5-25 (60-unit package), a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, which closes on August 19, 2025, was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $19,941.01 to AmerisourceBergen Drug Corp for the supply of Trelegy Ellipta 200-62.5-25, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a non-competitive, non-set-aside award. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location...
- The Defense Logistics Agency awarded a delivery order valued at $32,117.15 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 (60-count units), a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, awarded on August 7, 2025, was issued without a set-aside designation and is scheduled for completion by August 8, 2025. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania serves as the place...
- The Defense Logistics Agency awarded a delivery order valued at $28,804.38 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination respiratory medication indicated for chronic obstructive pulmonary disease management. The order was competitively awarded without set-aside designation and is scheduled for completion by September 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,585.83 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a competitively awarded non-set-aside contract. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,930.97 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product for respiratory treatment. The contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, operates under firm fixed price terms with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $25,630.25 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) on August 7, 2025, with completion scheduled for August 8, 2025. This non-competitive, firm fixed-price delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The product...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Trelegy Ellipta 100-62.5-25, a combination respiratory medication, with a ceiling value of $17,531.87. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, was competitively awarded without set-aside restrictions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $24,367.05 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease. The contract, awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, utilizes firm fixed pricing under a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $6,170.35 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Trelegy Ellipta 200-62.5-25 (60 count), a combination inhalation powder used to treat chronic obstructive pulmonary disease. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken,...